ebook Munafa Stock Market Course + Intraday & FNO calls  

       

PTCT announcements Ptc Therapeutics, Inc. announcements and dividends declared NASDAQ

Ptc Therapeutics, Inc. Complete list of announcements declared & dividend announcements by Ptc Therapeutics, Inc. PTCT

Ptc Therapeutics, Inc. PTCT listed on NASDAQ and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Ptc Therapeutics, Inc. PTCT

PTC Therapeutics (PTCT) Soars 5.8%: Is Further Upside Left in the Stock?
PTC Therapeutics (PTCT) shares rallied 5.8% in the last trading session to close at .60. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 3.1% gain over t
Announcement as on 10 January 2023

PTC Therapeutics (PTCT) Soars 5.8%: Is Further Upside Left in the Stock?
PTC Therapeutics (PTCT) shares rallied 5.8% in the last trading session to close at .60. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 3.1% gain over t
Announcement as on 10 January 2023

PTC Therapeutics shares fall 10% after announcing pause in U.S. enrollment for a clinical trial
Shares of PTC Therapeutics Inc. were down 10.1% in trading on Wednesday morning, the day after the company said enrollment in a Phase 2 clinical trial for its Huntington's disease treatment candidate has been paused. PTC told investors on Tuesday night th
Announcement as on 19 October 2022

PTC Therapeutics Granted Marketing Authorization By EU For Upstaza To Treat AADC Deficiency
(RTTNews) - PTC Therapeutics, Inc. (PTCT) announced Wednesday that Upstaza (eladocagene exuparvovec) was granted marketing authorization by the European Commission. Upstaza is the first approved disease-modifying treatment for aromatic L-amino acid decarbo
Announcement as on 20 July 2022

Announcements by Ptc Therapeutics, Inc. first page | Prev page |

PTCT Ptc Therapeutics, Inc. current price & indicator signals

Moving Averages for Ptc Therapeutics, Inc.

  • 5Day Average: 77.71
  • 12Day Average: 79.51
  • 20Day Average: 77.48
  • 50Day Average: 70.68
  • 100Day Average: 61.49
  • 150Day Average: 57.01
  • 200Day Average: 55.26

PTCT Indicators & signals

Indicator MACD (12,26,9)

78.35, 75.8, 3.24
Indicator MACD is in positive zone

Indicator ADX (14)

1.94, 22.82, 23.72
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 54
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of PTCT Ptc Therapeutics, Inc. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
05 Fri Dec 2025 77.25 76.54 to 78.68 -0.77% 0.25 times
04 Thu Dec 2025 77.85 74.83 to 79.03 2.76% 0.47 times
03 Wed Dec 2025 75.76 73.03 to 78.66 -3.49% 0.73 times
02 Tue Dec 2025 78.50 77.87 to 80.51 -0.88% 0.67 times
01 Mon Dec 2025 79.20 78.89 to 84.06 -7.9% 0.85 times
28 Fri Nov 2025 85.99 84.82 to 86.76 -0.3% 0.32 times
26 Wed Nov 2025 86.25 82.84 to 87.50 4% 4.53 times
25 Tue Nov 2025 82.93 81.89 to 85.61 3.88% 1.25 times
24 Mon Nov 2025 79.83 78.97 to 81.16 1.73% 0.34 times
21 Fri Nov 2025 78.47 75.34 to 79.98 2.63% 0.39 times
20 Thu Nov 2025 76.46 75.90 to 78.74 1.14% 0.43 times
19 Wed Nov 2025 75.60 75.52 to 76.89 -1.31% 0.3 times

Videos related to: PTCT announcements Ptc Therapeutics, Inc. announcements and dividends declared NASDAQ

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

PTCT announcements Ptc Therapeutics, Inc. announcements and dividends declared NASDAQ

 

Back to top